Maternally sequestered therapeutic polypeptides - a new approach for the management of preeclampsia
about
Placental origins of adverse pregnancy outcomes: potential molecular targets: an Executive Workshop Summary of the Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentDysregulated post-transcriptional control of COX-2 gene expression in gestational diabetic endothelial cellsEditorial: New therapeutic targets for human placental angiogenesis disease.Elastin-like polypeptides: Therapeutic applications for an emerging class of nanomedicines.A Maternally Sequestered, Biopolymer‐Stabilized Vascular Endothelial Growth Factor (VEGF) Chimera for Treatment of Preeclampsia.The Endothelin System: A Critical Player in the Pathophysiology of Preeclampsia.
P2860
Maternally sequestered therapeutic polypeptides - a new approach for the management of preeclampsia
description
2014 nî lūn-bûn
@nan
2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Maternally sequestered therape ...... the management of preeclampsia
@ast
Maternally sequestered therape ...... the management of preeclampsia
@en
Maternally sequestered therape ...... the management of preeclampsia
@nl
type
label
Maternally sequestered therape ...... the management of preeclampsia
@ast
Maternally sequestered therape ...... the management of preeclampsia
@en
Maternally sequestered therape ...... the management of preeclampsia
@nl
prefLabel
Maternally sequestered therape ...... the management of preeclampsia
@ast
Maternally sequestered therape ...... the management of preeclampsia
@en
Maternally sequestered therape ...... the management of preeclampsia
@nl
P2860
P356
P1476
Maternally sequestered therape ...... the management of preeclampsia
@en
P2093
Eric M George
P2860
P356
10.3389/FPHAR.2014.00201
P577
2014-09-05T00:00:00Z